<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report 34 patients (aged 5-18 years) with <z:hpo ids='HP_0011009'>acute</z:hpo> (n = 26) or <z:hpo ids='HP_0011010'>chronic</z:hpo> (n = 1) <z:hpo ids='HP_0001909'>leukemia</z:hpo>, non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (n = 3) or severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (n = 4) evaluated for pancreatic beta-cell function 9 months to 10.2 years after autologous (n = 19) or allogeneic (n = 15) BMT </plain></SENT>
<SENT sid="1" pm="."><plain>Before BMT, <z:hpo ids='HP_0000001'>all</z:hpo> patients received cytotoxic drugs, combined with total body irradiation (TBI) in 24 cases or thoracoabdominal irradiation (TAI) in 4 children </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were investigated for fasting blood <z:chebi fb="105" ids="17234">glucose</z:chebi> (FBG), HbA1C, anti-insulin (<z:mp ids='MP_0004157'>IAA</z:mp>) and islet cell antibodies (ICA), first-phase insulin response (FPIR) and insulinemia/glycemia (I/G) ratio on i.v. <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GTT</z:e>) and C-<z:chebi fb="7" ids="16670">peptide</z:chebi> response after glucagon 1 mg i.v </plain></SENT>
<SENT sid="3" pm="."><plain>Results were compared with those obtained in 21 age- and sex-matched controls </plain></SENT>
<SENT sid="4" pm="."><plain>None of the patients or controls had <z:mp ids='MP_0004157'>IAA</z:mp> and/or ICA </plain></SENT>
<SENT sid="5" pm="."><plain>FBG and HbA1C were <z:mpath ids='MPATH_458'>normal</z:mpath> in <z:hpo ids='HP_0000001'>all</z:hpo> children </plain></SENT>
<SENT sid="6" pm="."><plain>In the patients, glycemia on i.v </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GTT</z:e> was similar to controls whereas insulin levels I/G ratio and FPIR were significantly higher in patients than in controls, as well as C-<z:chebi fb="7" ids="16670">peptide</z:chebi> levels </plain></SENT>
<SENT sid="8" pm="."><plain>We divided the patients on the basis of the radiotherapy into group I with TBI (n = 18), group II with TAI (n = 4) and group III who were not irradiated (n = 4) </plain></SENT>
<SENT sid="9" pm="."><plain>The I/G ratio, FPIR on i.v </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GTT</z:e> and C-<z:chebi fb="7" ids="16670">peptide</z:chebi> response were significantly higher in group I compared with the other two groups and controls </plain></SENT>
<SENT sid="11" pm="."><plain>The increased insulin and C-<z:chebi fb="7" ids="16670">peptide</z:chebi> levels in our patients with <z:mpath ids='MPATH_458'>normal</z:mpath> glycemia might be interpreted as a state of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, more evident in patients who received <z:chebi fb="12" ids="9509">TBL</z:chebi> </plain></SENT>
</text></document>